Faes Farma revenue and financials
€4.61Change from previous close: +1.99%Absolute change: +€0.09
In the fiscal year ended December 2025, Faes Farma reported revenue of €610.46M (+23.66% year over year). Net income was €79.63M, a net margin of 13.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +23.66%
- 2025 vs 2024
- Net income growth
- −28.49%
- 2025 vs 2024
- Net margin
- 13.0%
- 2024: 22.6%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 610 | 494 | 451 | 439 |
| Cost of revenue | 215 | 167 | 154 | 157 |
| Gross profit | 396 | 327 | 297 | 282 |
| Selling, general and administrative | 91.7 | 65.8 | 57.4 | 52.5 |
| Research and development | 4.9 | 5.8 | 5.2 | 3.7 |
| Operating income | 91.1 | 110 | 104 | 102 |
| EBIT | 91.3 | 108 | 103 | 102 |
| EBITDA | 120 | 128 | 123 | 121 |
| Interest expense | 5.9 | 0.4 | 0.4 | 0.3 |
| Pre-tax income | 85.4 | 108 | 103 | 101 |
| Income tax | 5.8 | -3.5 | 11.2 | 12.0 |
| Net income | 79.6 | 111 | 91.9 | 89.5 |
| Net income to common shareholders | 79.6 | 111 | 91.9 | 89.5 |
| Basic EPS | 0.26 | 0.36 | 0.30 | 0.29 |
| Diluted EPS | 0.25 | 0.36 | 0.30 | 0.29 |
| Average shares (basic) | 311 | 311 | 310 | 306 |
| Average shares (diluted) | 313 | 312 | 311 | 306 |